Publicaciones en las que colabora con F. Manzarbeitia (7)

2005

  1. Serenoa repens treatment modifies Bax/Bcl-2 index expression and Caspase-3 activity in prostatic tissue from patients with benign prostatic hyperplasia

    Journal of Urology, Vol. 173, Núm. 2, pp. 507-510

2004

  1. Aspirin inhibits endothelial nitric oxide synthase (eNOS) and Flk-1 (vascular endothelial growth factor receptor-2) prior to rat colon tumour development

    Clinical Science, Vol. 106, Núm. 1, pp. 83-91

2003

  1. BPH and Inflammation: Pharmacological Effects of Permixon on Histological and Molecular Inflammatory Markers. Results of a Double Blind Pilot Clinical Assay

    European Urology, Vol. 44, Núm. 5, pp. 549-555

2002

  1. Benign prostatic hyperplasia: biological significance of lymphohistiocytic infiltration of the adenoma

    Actas urologicas españolas, Vol. 26, Núm. 3, pp. 163-173

2001

  1. Aspirin protected the nitric oxide/cyclic GMP generating system in human peritoneum

    Peritoneal Dialysis International, Vol. 21, Núm. SUPPL. 3

1996

  1. Role of endothelin in the pathophysiology of renal ischemia-reperfusion in normal rabbits

    Kidney International, Vol. 50, Núm. 3, pp. 776-782

  2. Role of endothelium-related mechanisms in the pathophysiology of renal ischemia/reperfusion in normal rabbits

    Circulation Research, Vol. 79, Núm. 5, pp. 1031-1038